Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells

Slagelse Hospital

Status: Completed

Conditions: Rectal Cancer

Treatments: Procedure: Rectal washout

Study type: Observational

Funder types: Other

Identifiers

NCT04730102

ALF Region Skåne (Other Grant/Funding Number)

2019-2567 (Other Grant/Funding Number)

SJ-817

Details and patient eligibility

About

The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal cancer.

Full description

Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity. Each sample is cytologically examined by a pathologist and labelled either malignant or non-malignant.

Enrollment: 21 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Surgery at Slagelse Hospital for rectal cancer with transanal mesorectal excision
• Consent to participate in the study

Exclusion criteria

• No consent to participate
• No surgery

Trial design

21 participants in 1 patient group

Patients undergoing rectal washout in transanal mesorectal excision

Description:

Patients undergoing rectal washout in transanal mesorectal excision for rectal cancer.

Treatment:

Procedure: Rectal washout